Literature DB >> 9241410

Use of psychotropic medication in Oklahoma: a statewide survey.

S Spreat1, J W Conroy, J C Jones.   

Abstract

Analysis of statewide survey data revealed that 22.5% of individuals with mental retardation who were served by the Oklahoma mental retardation system were receiving antipsychotic medication. Anxiolytic medications were prescribed for 9.3%, and antidepressants were prescribed for 5.9%. Higher levels of medication use were found in institutional settings and Intermediate Care Facility settings.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9241410     DOI: 10.1352/0895-8017(1997)102<0080:UOPMIO>2.0.CO;2

Source DB:  PubMed          Journal:  Am J Ment Retard        ISSN: 0895-8017


  3 in total

1.  International guide to prescribing psychotropic medication for the management of problem behaviours in adults with intellectual disabilities.

Authors:  Shoumitro Deb; Henry Kwok; Marco Bertelli; Luis Salvador-Carulla; Elspeth Bradley; Jennifer Torr; Jarret Barnhill
Journal:  World Psychiatry       Date:  2009-10       Impact factor: 49.548

Review 2.  Psychopharmacological treatments in persons with dual diagnosis of psychiatric disorders and developmental disabilities.

Authors:  R Antochi; C Stavrakaki; P C Emery
Journal:  Postgrad Med J       Date:  2003-03       Impact factor: 2.401

3.  Brief report: clonazepam behavioral side effects with an individual with mental retardation.

Authors:  John E Kalachnik; Thomas E Hanzel; Robert Sevenich; Stuart R Harder
Journal:  J Autism Dev Disord       Date:  2003-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.